2026, Vol 16

Editor-in-Chief

Original Research

1. Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro

Jalil Pirayesh Islamian*, Mohsen Mohammadi, Behzad Baradaran, Alireza Farajollahi, Seyed Mahmoud Reza Aghamiri, Mohammad Asghari Jafarabadi, Haadi Karami, Amir Monfaredan, Dariuosh Shanehbandi

Bioimpacts. 2016;6(2): 93-98. doi: 10.15171/bi.2016.13

PMCID: PMC4981254 PMID: 27525226 Scopus ID: 84983516628

Article

PDF

XML

Cited By:

Original Research

2. Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy

Ranjita Misra* , Bamadeb Patra, Sudha Varadharaj, Rama Shanker Verma*

BioImpacts. 2021;11(3): 199-207. doi: 10.34172/bi.2021.27

PMCID: PMC8314031 PMID: 34336608 Scopus ID: 85109081197

Article

PDF

Full Text

XML

Cited By:

Formulation of siRNA adsorbed drug loaded cationic PLGA NPs. Treatment of cells with siRNA adsorbed drug loaded cationic NPs leads to endosomal escape of drugs and siRNA, thereby increasing the efficiency of the therapeutic components inducing more cytotoxicity.

Review

3. Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance

Dilpreet Singh* , Akshay Kumar, Vir Vikram Sharma

Bioimpacts. 2025;15: 31475 | Published on: 2025 Nov 10. doi: 10.34172/bi.31475

PMCID: PMC12705286 PMID: 41409587

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Mini Review

4. Short interference RNAs in glomerulonephritis: A mini review

Negin Frounchi , Diana Jafari Nakhjavani, Sima Abediazar, MohammadReza Ardalan, Farahnoosh Farnood*

Bioimpacts. 2026;16: 32812 | Published on: 2026 Jun 30. doi: 10.34172/bi.32812

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 19%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons